Dexmedetomidine and Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
DexmedetomidineKetamineExternal Oblique Intercostal Plane BlockPost Thoracotomy Pain
Interventions
DRUG

Ketamine

Patients will receive external oblique intercostal plane block using 29 ml bupivacaine 0.25% + 1 ml ketamine (50 mg) after induction of general anesthesia.

DRUG

Dexmedetomidine

Patients will receive external oblique intercostal plane block using 29 ml bupivacaine 0.25% + 1 ml dexmedetomidine 0.5 μg/kg after induction of general anesthesia.

DRUG

Bupivacaine

29 ml bupivacaine 0.25%

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06331182 - Dexmedetomidine and Ketamine as an Adjuvant in External Oblique Intercostal Plane Block for Post Thoracotomy Pain | Biotech Hunter | Biotech Hunter